2019/06/28 08:11:12 | |
---|---|
Price | |
76.50 EUR | |
Difference | 0.60% (0.46) |
ISIN | CH1175448666 |
Symbol | STMN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 20,772 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 76.50 EUR |
High | 765.00 EUR |
Low | 765.00 EUR |
Close (prev. day) | 76.04 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | 14 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings | ||
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings |
2019/06/28 08:11:12 | |
---|---|
Price | |
76.50 EUR | |
Difference | 0.60% (0.46) |
ISIN | CH1175448666 |
Symbol | STMN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 20,772 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 76.50 EUR |
High | 765.00 EUR |
Low | 765.00 EUR |
Close (prev. day) | 76.04 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 1.23 | 1.27 | 1.63 |
Volatility | - | - | - |
Ø price 5 days | Ø volume 5 days (pcs.) | - EUR (-) |
Ø price 30 days | Ø volume 30 days (pcs.) | - EUR (-) |
Ø price 100 days | Ø volume 100 days (pcs.) | - EUR (-) |
Ø price 250 days | Ø volume 250 days (pcs.) | - EUR (-) |
YTD High | date | - EUR (-) |
YTD Low | date | - EUR (-) |
52 Weeks High | date | - EUR (-) |
52 Weeks Low | date | - EUR (-) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
SIX Swiss Exchange | 2024/08/16 | 17:31 | 124.80 CHF | 43.38 | 3,934 |
London Stock Exchange European Trade Reporting | 2024/08/14 | 09:29 | 124.50 CHF | 1.28 | 6 |
Frankfurt | 2019/06/28 | 10:55 | 77.80 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/08/16 | 21:23 | 139.598 USD | 0.04 | 13 |
Duesseldorf | 2019/06/28 | 08:11 | 76.50 EUR | 0.00 | 2 |
STRAUMANN HOLDING AG |
- - |
Peter Merian-Weg 12 - 4002 Basel |
Telefon: +41-61-965-11-11 |
Fax: +41-61-965-11-01 |
E-mail: info@straumann.com |
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Western Europe, Sales Central Eastern Europe, Middle East and Africa (CEEMEA), Sales North America (NAM), Sales Asia Pacific (APAC), Sales Latin America (LATAM), and Operations. The Sales Western Europe segment comprises Groupšs distribution businesses in Scandinavia, the UK, France, the Benelux countries, Iberia and Italy; implant-borne prosthetics business of Createch, as well as Anthogyr manufacturing plants, a French company that develops and manufactures dental implant systems and CADCAM solutions. The Sales CEEMEA segment comprises the Group's distribution businesses mainly in Germany, Switzerland, Austria, Hungary, the Czech Republic, Russia, Turkey, Croatia, Jordan and South Africa, as well as the business with European, African and Middle Eastern distributors. The Sales NAM segment comprises ClearCorrectšs clear-aligner business and its associated development and production activities. The Sales APAC segment comprises Groupšs distribution businesses in the Asia pacific region, as well as the business with Asian distributors. The Sales LATAM segment comprises distribution and Instradent businesses in Middle and South America, and Latin America. The Operations segment manufactures plants, implants, and biomaterials. The company was founded by Reinhard Straumann in 1954 and is headquartered in Basel, Switzerland. |
Guillaume Daniellot | Chairman of Managing Board |
Andreas Meier | Member of Executive Committee |
Christian Ullrich | Member of Executive Committee |
Alastair Robertson | Member of Executive Committee |
Aurelio Sahagun | Member of Executive Committee |
Holger Haderer | Member of Executive Committee |
Jason Forbes | Member of Executive Committee |
Marcel Kellerhals | Member of Executive Committee |
Matthias Schupp | Member of Executive Committee |
Patrick Loh | Member of Executive Committee |
Sébastien Roche | Member of Executive Committee |
Wolfgang Becker | Member of Executive Committee |
Yang Xu | Member of Executive Committee |
H. C. Straumann | Member of the administrative board |
Olivier Filliol | Member of the administrative board |
Marco Gadola | Member of the administrative board |
Regula Wallimann | Member of the administrative board |
Stefan Mario Meister | Member of the administrative board |
Xiaoqun Clever-Steg | Member of the administrative board |
Petra Rumpf | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer